Report Detail

Other Global Parkinson's Disease Treatment Market Size, Status and Forecast 2019-2025

  • RnM3430617
  • |
  • 21 July, 2020
  • |
  • Global
  • |
  • 99 Pages
  • |
  • QYResearch
  • |
  • Other

Parkinson's Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharmaceutical Industries
Wockhardt
Acadia Pharmaceuticals
UCB

Market segment by Type, the product can be split into
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Parkinson's Disease Treatment Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Parkinson's Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Levodopa/carbidopa
    • 1.4.3 Dopamine Receptor Agonists
    • 1.4.4 MAO-Inhibitors
    • 1.4.5 COMT-inhibitors
    • 1.4.6 Anticholinergics
  • 1.5 Market by Application
    • 1.5.1 Global Parkinson's Disease Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Parkinson's Disease Treatment Market Perspective (2015-2026)
  • 2.2 Global Parkinson's Disease Treatment Growth Trends by Regions
    • 2.2.1 Parkinson's Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Parkinson's Disease Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Parkinson's Disease Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Parkinson's Disease Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Parkinson's Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Parkinson's Disease Treatment Players by Market Size
    • 3.1.1 Global Top Parkinson's Disease Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Parkinson's Disease Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Parkinson's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Parkinson's Disease Treatment Market Concentration Ratio
    • 3.2.1 Global Parkinson's Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatment Revenue in 2019
  • 3.3 Parkinson's Disease Treatment Key Players Head office and Area Served
  • 3.4 Key Players Parkinson's Disease Treatment Product Solution and Service
  • 3.5 Date of Enter into Parkinson's Disease Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Parkinson's Disease Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Parkinson's Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Parkinson's Disease Treatment Market Size by Application (2015-2020)
  • 5.2 Global Parkinson's Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Parkinson's Disease Treatment Market Size (2015-2020)
  • 6.2 Parkinson's Disease Treatment Key Players in North America (2019-2020)
  • 6.3 North America Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 6.4 North America Parkinson's Disease Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Parkinson's Disease Treatment Market Size (2015-2020)
  • 7.2 Parkinson's Disease Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 7.4 Europe Parkinson's Disease Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China Parkinson's Disease Treatment Market Size (2015-2020)
  • 8.2 Parkinson's Disease Treatment Key Players in China (2019-2020)
  • 8.3 China Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 8.4 China Parkinson's Disease Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Parkinson's Disease Treatment Market Size (2015-2020)
  • 9.2 Parkinson's Disease Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 9.4 Japan Parkinson's Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Parkinson's Disease Treatment Market Size (2015-2020)
  • 10.2 Parkinson's Disease Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Parkinson's Disease Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India Parkinson's Disease Treatment Market Size (2015-2020)
  • 11.2 Parkinson's Disease Treatment Key Players in India (2019-2020)
  • 11.3 India Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 11.4 India Parkinson's Disease Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Parkinson's Disease Treatment Market Size (2015-2020)
  • 12.2 Parkinson's Disease Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Parkinson's Disease Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America Parkinson's Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GSK
    • 13.1.1 GSK Company Details
    • 13.1.2 GSK Business Overview
    • 13.1.3 GSK Parkinson's Disease Treatment Introduction
    • 13.1.4 GSK Revenue in Parkinson's Disease Treatment Business (2015-2020))
    • 13.1.5 GSK Recent Development
  • 13.2 Merck
    • 13.2.1 Merck Company Details
    • 13.2.2 Merck Business Overview
    • 13.2.3 Merck Parkinson's Disease Treatment Introduction
    • 13.2.4 Merck Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.2.5 Merck Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Parkinson's Disease Treatment Introduction
    • 13.3.4 Novartis Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Teva
    • 13.4.1 Teva Company Details
    • 13.4.2 Teva Business Overview
    • 13.4.3 Teva Parkinson's Disease Treatment Introduction
    • 13.4.4 Teva Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.4.5 Teva Recent Development
  • 13.5 Boehringer Ingelheim
    • 13.5.1 Boehringer Ingelheim Company Details
    • 13.5.2 Boehringer Ingelheim Business Overview
    • 13.5.3 Boehringer Ingelheim Parkinson's Disease Treatment Introduction
    • 13.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.5.5 Boehringer Ingelheim Recent Development
  • 13.6 Impax
    • 13.6.1 Impax Company Details
    • 13.6.2 Impax Business Overview
    • 13.6.3 Impax Parkinson's Disease Treatment Introduction
    • 13.6.4 Impax Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.6.5 Impax Recent Development
  • 13.7 Abbvie
    • 13.7.1 Abbvie Company Details
    • 13.7.2 Abbvie Business Overview
    • 13.7.3 Abbvie Parkinson's Disease Treatment Introduction
    • 13.7.4 Abbvie Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.7.5 Abbvie Recent Development
  • 13.8 Bausch Health
    • 13.8.1 Bausch Health Company Details
    • 13.8.2 Bausch Health Business Overview
    • 13.8.3 Bausch Health Parkinson's Disease Treatment Introduction
    • 13.8.4 Bausch Health Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.8.5 Bausch Health Recent Development
  • 13.9 Lundbeck
    • 13.9.1 Lundbeck Company Details
    • 13.9.2 Lundbeck Business Overview
    • 13.9.3 Lundbeck Parkinson's Disease Treatment Introduction
    • 13.9.4 Lundbeck Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.9.5 Lundbeck Recent Development
  • 13.10 Sun Pharmaceutical Industries
    • 13.10.1 Sun Pharmaceutical Industries Company Details
    • 13.10.2 Sun Pharmaceutical Industries Business Overview
    • 13.10.3 Sun Pharmaceutical Industries Parkinson's Disease Treatment Introduction
    • 13.10.4 Sun Pharmaceutical Industries Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 13.10.5 Sun Pharmaceutical Industries Recent Development
  • 13.11 Wockhardt
    • 10.11.1 Wockhardt Company Details
    • 10.11.2 Wockhardt Business Overview
    • 10.11.3 Wockhardt Parkinson's Disease Treatment Introduction
    • 10.11.4 Wockhardt Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 10.11.5 Wockhardt Recent Development
  • 13.12 Acadia Pharmaceuticals
    • 10.12.1 Acadia Pharmaceuticals Company Details
    • 10.12.2 Acadia Pharmaceuticals Business Overview
    • 10.12.3 Acadia Pharmaceuticals Parkinson's Disease Treatment Introduction
    • 10.12.4 Acadia Pharmaceuticals Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 10.12.5 Acadia Pharmaceuticals Recent Development
  • 13.13 UCB
    • 10.13.1 UCB Company Details
    • 10.13.2 UCB Business Overview
    • 10.13.3 UCB Parkinson's Disease Treatment Introduction
    • 10.13.4 UCB Revenue in Parkinson's Disease Treatment Business (2015-2020)
    • 10.13.5 UCB Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Parkinson's Disease Treatment . Industry analysis & Market Report on Parkinson's Disease Treatment is a syndicated market report, published as Global Parkinson's Disease Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Parkinson's Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,611.40
    5,417.10
    7,222.80
    590,265.00
    885,397.50
    1,180,530.00
    325,260.00
    487,890.00
    650,520.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report